Tech Mahindra & NVIDIA: Harnessing AI to Protect Lives through Enhanced Drug Safety

Tech Mahindra and NVIDIA have entered into a strategic partnership to improve drug safety management using an AI-driven pharmacovigilance solution. The cutting-edge solution uses agentic AI and automation to enhance the accuracy, speed, and efficiency of pharmacovigilance operations. It solves industry problems like manual delays and data overload by automating processes such as case intake, data transformation, and compliance management. The solution decreases turnaround times by as much as 40%, improves data accuracy by 30%, and reduces operational expenses by 25%. The partnership is expected to transform drug safety through the incorporation of NVIDIA AI Enterprise software into Tech Mahindra's TENO framework.

 

Sources: PR Newswire, Tech Mahindra Insights, Business Standard